mk 996 has been researched along with angiotensin ii, sar(1)-ile(5)- in 1 studies
Studies (mk 996) | Trials (mk 996) | Recent Studies (post-2010) (mk 996) | Studies (angiotensin ii, sar(1)-ile(5)-) | Trials (angiotensin ii, sar(1)-ile(5)-) | Recent Studies (post-2010) (angiotensin ii, sar(1)-ile(5)-) |
---|---|---|---|---|---|
8 | 0 | 1 | 43 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbera, FA; Bernard, R; Bozarth, TA; Gibson, RE; Herblin, WF; Watson, CA; Wong, PC | 1 |
1 other study(ies) available for mk 996 and angiotensin ii, sar(1)-ile(5)-
Article | Year |
---|---|
Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Imidazoles; Losartan; Male; Pyridines; Rats; Rats, Sprague-Dawley; Sulfonamides; Tetrazoles | 1996 |